3:02 1. Guard against thesis creep — re-underwrite, don't re-rationalize
The repeatable method
- When a position drops hard, separate the price action from the thesis. Write down the original thesis verbatim before reacting.
- Ask only: did this quarter break a load-bearing pillar of that thesis, or just hit a data point investors fixate on? If the pillars hold, the drop is an entry, not an exit.
- Refuse to quietly edit the thesis to fit the new price ("have the tail wag the dog"). Either the pillars are intact (add/hold) or one broke (sell) — no middle "it's complicated."
Here: CHTR −25% on a 120k broadband-sub loss — but the two pillars (CapEx rolling off into FCF/buybacks; cheapest converged bundle) were untouched, so he
added on the dip (
5:48).
Watch for
- Any large drawdown in a held name — test it against the written pillars, not against the new price. The sub-count miss vs the CapEx/buyback math is the model case.
3:24 2. The CapEx-rolloff → FCF → buyback engine — value a self-liquidating cheap stock
The repeatable method
- Find a company finishing a multi-year capital build whose CapEx is scheduled to fall sharply. Each dollar of declining CapEx drops "dollar for dollar" into free cash flow.
- Map the outer-year FCF against the current market cap to get a free-cash-flow yield (FCF ÷ market cap). A double-digit-plus yield with a tiny cap means the buyback can retire a huge share of the float.
- Frame the disconnect explicitly: at the current price the market must be implying either CapEx won't fall, buybacks won't happen, or earnings collapse. If none is credible, the stock is mispriced — but accept "cheap can stay cheap," so size it as a wait.
- Demand a low-cost competitive edge so the operating business doesn't erode while you wait.
Here: CHTR — CapEx 11B→9.5B→7.5–8B (2026–29), ~70% FCF yield in the outer years on a $23B cap, buying back up to 50% of shares; edge = $100 converged bundle vs $180–200 rivals; 2026 PE ~4×.
Watch for
- Capital-cycle names rolling off peak CapEx with a small market cap and a structural cost edge; the implied-market-disbelief test as the mispricing signal.
14:52 3. The cheap-stock turnaround template — find the analog that already worked
The repeatable method
- For a contested cheap-stock turnaround, point to a completed precedent: a name that was equally cheap and hated, then "started to perform" and re-rated multiples-fold.
- Confirm the precedent is performing on fundamentals (beats across the board + raised guidance), not just multiple expansion, so the analogy is operational, not hopeful.
- Use it to set the payoff shape for the open idea — what "it works" looks like in price terms.
Here: GM $27 (Nov 2023) → $78, beating across the board (rev 43.6B, EPS 3.70 vs 2.60) with raised guidance, is the template "for what I'm hoping for with Charter."
Watch for
- A clean, recent turnaround in an unrelated sector you can hold up as the proof-of-concept for an in-progress cheap-stock bet.
13:38 4. Read the K-shaped consumer through cheap-staple same-store sales
The repeatable method
- Pick a low-ticket, everyday brand (pizza, fast food) as the bottom-of-the-K gauge — when even cheap discretionary softens, the lower/middle consumer is stressed.
- Read its same-store sales (sales at locations open ≥1 yr) vs estimate — the single cleanest retail-health metric — alongside EPS direction.
- Triangulate against a top-of-the-funnel spending read (a card network) to confirm the split: aggregate spend strong while the value brand is weak = K-shaped, not broad recession.
Here: DPZ SSS +0.9% vs 2.3% est, EPS −5%, −8% → "bottom of the K… in a deep recession," even as V net rev +17% / payment volume +9% says the overall consumer still spends.
Watch for
- The spread between a value brand's SSS and a payments network's volume each earnings season — widening = the K is steepening.
11:26 5. The refinancing-not-the-mark question — stress private-credit software loans by the equity cushion
The repeatable method
- Distrust lender "risk buckets" that only say borrowers are current now ("low risk" ≠ refinanceable). Ask the forward question: who refinances this loan at maturity?
- Proxy the private-equity-owned borrower's equity value with a comparable public peer's drawdown. If the public comp is down ~60%, assume the private equity cushion is worth <½ original cost.
- When the equity beneath a loan is worth less than half, flag refinancing risk for the whole BDC/private-credit chain regardless of current marks.
- Cross-check the manager's own quality: a negative direct-lending quarter, heavy add-back-driven "adjusted" earnings, and GAAP-thin profitability are tells the reported numbers flatter reality.
Here: NOW −60% as the software proxy → ARCC's 85% "low-risk" software loans likely sit on <½-cost equity; OWL direct lending −40bps, $196M stock comp (50% over consensus), "barely profitable" under GAAP.
Watch for
- Public software comps' drawdowns as the proxy; loan-maturity walls; alt-manager stock-comp add-backs that turn a GAAP loss into "adjusted" profit.
18:21 6. Quantify the pricing-war wipeout — model the unit economics, not the guidance
The repeatable method
- When a regulator is about to clear a cheaper substitute, ignore management's "we won't lose share" and build the buyer's actual per-unit cost both ways.
- Use the real funnel (e.g. ~30% of mortgage applications fund) so per-funded-loan fees get weighted correctly, then compute total cost per 100 transactions for each product.
- If the ratio is lopsided (here ~20×), treat "won't lose share" as the high-risk assumption and the regulatory-approval + pilot/rollout calendar as the catalyst path.
- Flag structural conflicts that worsen the odds (a monopoly buying inputs from the very competitors now undercutting it).
Here: FICO Score 10 T = $2,049 per 100 apps (99¢×100 + $65×30) vs VantageScore $99 — a 20-to-1 gap; FHFA approval in months, pilots 2026 / full 2027; FICO pulls data from the three bureaus it now competes with. Short for several months.
Watch for
- Regulatory approvals that admit a cheaper "good-enough" substitute; per-transaction cost gaps wide enough that "good enough" wins on price.
20:38 7. The "lacks a thesis" filter — require a reason to move before owning a fallen stock
The repeatable method
- For a beaten-down name, separate "cheap" from "investable." A multi-year price collapse plus "in line" guidance with no sign of improvement is not a setup.
- State the missing piece plainly: with no identifiable catalyst or reason the business inflects, there is no thesis — and "an inexpensive stock does not necessarily make a good investment."
- Pass until a concrete reason to re-rate appears; don't buy hope every quarter.
Here: ENPH $335 (2022) → $33, EPS −31%, Q2 guide "in line" but no improvement — "the stock lacks a thesis," so there's no case to own it (contrast with CHTR, which has an explicit one).
Watch for
- Serially-falling stocks where every quarter is "in line, no improvement" — the absence of a catalyst is itself the signal to stay out.
9:20 8. Watch the concentration tells — semis weight and the single-headline tape
The repeatable method
- Track a single subsector's share of the index against its own history; an all-time-high weight means index-level moves are hostage to that one theme's news.
- Confirm the fragility on the tape: a lone story (e.g. one AI revenue/data-center headline) producing a one-day correction across semis, infotech and the Nasdaq proves the concentration.
- Note the non-confirmations that complicate the macro narrative (an asset not behaving per its textbook role) and keep them on a watch-list rather than forcing a conclusion.
Here: semis a record 16% of the S&P (46% of infotech), software down to 8% from 12% (Aug 2025); a single WSJ OpenAI story sparked a one-day semi/Nasdaq correction; gold "did nothing" during the war — "I'm not sure what this means, but it's worth watching."
Watch for
- Subsector index weights at record highs; single-headline whole-index moves; classic hedges (gold) failing to behave — each a structural-risk flag.